A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746).

  • Park, Yeon Hee
  • Kim, Tae Yong
  • Kim, Gun Min
  • Jung, Kyung Hae
  • Kang, Seok Yun
  • ... Lee, Moon Hee
  • 외 14명
Citations

WEB OF SCIENCE

13
제목
A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746).
저자
Park, Yeon HeeKim, Tae YongKim, Gun MinJung, Kyung HaeKang, Seok YunPark, In HaeKim, Jee HyunLee, Kyoung EunAhn, Hee KyungLee, Moon HeeKim, Hee JunKim, Han JoLee, Jong InKoh, Su-JinKim, Ji-YeonLee, Kyung-HunSohn, JoohyukKim, Sung-BaeIm, Young-HyuckIm, Seock-Ah
DOI
10.1200/JCO.2019.37.15_suppl.1007
발행일
2019-05
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
37
15